TPTX insider trading
Turning Point Therapeutics, Inc.: insider trade history from SEC Form 4 filings.
TPTX insider activity at a glance
FilingIQ tracks 334 insider transactions for TPTX in filings since Apr 24, 2019. The most recent transaction is dated Aug 17, 2022.
Across the full history, 16 open-market purchases
and 252 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on TPTX insider trades is 62.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest TPTX Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Frequently asked
- How many insider trades does FilingIQ track for TPTX?
- FilingIQ tracks 334 Form 4 insider transactions for TPTX (Turning Point Therapeutics, Inc.), covering filings from Apr 24, 2019 onwards. 0 of those are dated within the last 90 days.
- Are TPTX insiders net buyers or net sellers?
- Across the full Form 4 history for TPTX, 16 transactions (5%) were open-market purchases and 252 (75%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does TPTX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
Methodology & sources
Every TPTX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.